International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.
International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.
Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.
Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.
Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.
Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.
Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.
International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.
Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.
Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.
Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.
An International Open Access Journal Devoted to General Medicine.
Mol Med Rep 24: [Related article:] 874, 2021; DOI: 10.3892/mmr.2021.12514
Subsequently to the publication of the above article, a concerned reader has drawn the Editor's attention to the fact that a pair of inappropriately selected antibodies were reported to have been used to probe for phosphorylated ERK (or p-ERK) in the western blot experiments shown in Fig. 6A on p. 8: The catalogue numbers for the antibodies were reported in the Materials and methods section to have been ab229912 and ab192591 (purchased from Abcam), whereas these antibodies do not target p-ERK, but protein kinase RNA-like ER kinase (also known as EIF2AK3), having the acronym ‘PERK’.
The authors have been contacted by the Editorial Office to offer an explanation for the apparently inappropriate selection of these two antibodies in this paper, and we are awaiting their response. Owing to the fact that the Editorial Office has been made aware of this potential issue surrounding the scientific integrity of this paper, we are issuing an Expression of Concern to notify readers of this potential problem while the Editorial Office continues to investigate this matter further.